< Zurück zu den aktuellen Neuigkeiten & Events

Neuigkeiten

Co-Existence Agreements – The importance of getting them right

Juni 2020

A co-existence agreement allows businesses to trade using the same (or similar) mark, but with certain agreed restrictions, such as geographical constraints where a mark can be used. For example – one party may be able to sell under the mark in Europe, and another can sell under the mark in the USA. The need for this may arise for example where two parties have unknowingly adopted the same mark at the same time.

The recent case of Merck KGaA v Merck Sharp & Dohme Corp and Ors [2020] EWHC 1273 (Ch) concerned a long running trade mark dispute between Merck KGaA (Merck Global) and Merck Sharp & Dohme Corporation (Merck US) and illustrates the importance of making sure co-existence agreements are fit for purpose.

Background

Merck Global was founded in 1688 in Germany. A US subsidiary was established that subsequently became an independent company. A co-existence agreement was entered into in 1955 and then updated in 1970, which set out the parties use of the mark ‘Merck’. This agreement provided that Merck US were fine to use this mark in the US and Canada, however in other countries they would use ‘Merck Sharp & Dohme’ (the company’s full name).

Infringement

Merck Global claimed that online and offline uses of ‘Merck’ in the UK by Merck US breached the co-existence agreement between the parties. In 2016, the High Court found that Merck US’ use of the mark in the UK constituted a breach of the co-existence agreement. Merck US appealed, and the Court of Appeal found in 2017 that Merck US had breached the agreement. The issues of whether these breaches constituted trade mark infringement were referred back to the High Court.

The judge found that Merck US’ use of the mark on websites, email addresses and social media targeted at the UK could constitute “use in the course of trade” (i.e. – physical goods do not actually have to be available, given the fact that Merck US had used a different mark on products actually sold in the UK) and accordingly use in this way constituted trade mark infringement. An injunction was granted against Merck US to prevent it from infringing the mark in the UK.

How can a business get this right?

Ensuring that a co-existence agreement will adequately deal with every eventuality that may arise in the future is obviously impossible. However, the co-existence agreement in this instance appeared to be very simple and had not been updated since 1970 (and consequently could never deal with issues such as whether use on social media constituted infringement). Parties to such an agreement should therefore think about the following;

  • What effect could rapidly evolving technology have on the use of a mark in future. Could this widen the use of a mark, sometimes inadvertently beyond the scope of what was originally intended?
  • Where do you realistically intend to sell products? Basing an agreement on current markets and ignoring potential markets could cause problems down the line.
  • Include adequate dispute resolution processes (for example a requirement to mediate a dispute) in order to hopefully avoid costly and lengthy litigation.
  • Given this case and the effects of the internet and other technology, it may be worthwhile introducing requirements for the agreement to be reviewed (for example every ten years) to make sure it adequately provides for such advancements or changes to the parties’ businesses
  • Don’t just consider geography – consider all elements of hard copy and electronic use including social media, websites, physical marketing brochures and other advertising materials.

This article was prepared by HGF Senior IP Solicitor Chris Robinson. If you would like further advice on this or any other matter, please contact Chris.  Alternatively, you can contact your usual HGF representative or visit our Contact page to get in touch with your nearest HGF office.

Aktuelle Neuigkeiten

Doubling Up on Added Matter at the UPC

Following the UPC Court of Appeal (CoA) decision in Abbott v Sibio (APL_39664/2024, 14 February 2025) we now have a second CoA decision on added matter in expert Klein v …

Weiterlesen
Event - 4. November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Veranstaltungsdetails
Event - 30. bis 31. Oktober 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Veranstaltungsdetails

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Weiterlesen

Agritech Thymes: Die Gefahr der stillschweigenden Zustimmung: Lehren aus dem Fall „Pink Lady“

Kann die Lieferung einer Pflanzensorte ohne klare und definierte Nutzungsbeschränkungen als stillschweigende Zustimmung zu ihrer Vermarktung angesehen werden? Im Mittelpunkt dieses Falls stehen die Beweise, die erforderlich sind, um „ernsthafte …

Weiterlesen

IAM Global Leaders 2026

HGF is proud to announce that we have 3 partners listed as an IAM Global Leader 2026. To qualify for inclusion in the IAM Global Leaders, individuals must be ranked …

Weiterlesen

The Bite of Implied Consent: Lessons from the Pink Lady Case

A recent European Union court decision considers the issue of implied consent to commercialise a plant variety, and whether the evidence meets the threshold of “serious doubts” of the validity …

Weiterlesen
Event - 5. November 2025

HGF ist Gold-Sponsor von IAM Live: Navigating the UPC 2025

Wir freuen uns, Ihnen mitteilen zu können, dass HGF Gold-Sponsor von IAM Live: Navigating the UPC 2025 ist, das am 5. November im Marriott Opera Ambassador Hotel in Paris stattfindet. …

Veranstaltungsdetails